Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Histologic Type

Explore clinical trials studying Neoplasms by Histologic Type. Study availability and eligibility vary by location and protocol.

30,084 public trials 6,466 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Histologic Type trial results

Terminated

A Phase II Study of Nivolumab + Ipilimumab in Advanced HCC Patients Who Have Progressed on First Line Atezolizumab + Bevacizumab

NCT05199285

Conditions
Adenocarcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, +19 more
Locations
  • University of Alabama- Birmingham Birmingham, Alabama, United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
View Trial Details
Terminated

Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC)

NCT03869190

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
Locations
  • UCLA Department of Medicine Los Angeles, California, United States
  • UCSF Comprehensive Cancer Ctr San Francisco, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • University of Kentucky Chandler Medical Center Lexington, Kentucky, United States
View all 33 locations
View Trial Details
Suspended

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

NCT05691478

Conditions
High Grade Osteosarcoma, Localized Osteosarcoma, Metastatic Osteosarcoma, +8 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
View all 202 locations
View Trial Details
Suspended

Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma

NCT06232044

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Mary Greeley Medical Center Ames, Iowa, United States
  • McFarland Clinic - Ames Ames, Iowa, United States
  • McFarland Clinic - Boone Boone, Iowa, United States
  • McFarland Clinic - Trinity Cancer Center Fort Dodge, Iowa, United States
View all 43 locations
View Trial Details

Related conditions